Header Logo

Stacey Honda

Concepts (199)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
11
2025
260
1.790
Why?
Early Detection of Cancer
13
2025
513
1.100
Why?
Microbiota
1
2022
4
0.820
Why?
Multiple Myeloma
2
2014
9
0.810
Why?
Colorectal Neoplasms
4
2022
615
0.800
Why?
Adenoma
1
2022
94
0.740
Why?
Skin Neoplasms
3
2024
57
0.620
Why?
Humans
37
2025
17822
0.520
Why?
Proteostasis Deficiencies
1
2014
1
0.460
Why?
Amyloidosis
1
2014
3
0.460
Why?
Mass Screening
5
2025
678
0.380
Why?
Male
17
2025
10145
0.380
Why?
Quality Improvement
2
2024
194
0.360
Why?
Immunoglobulin D
1
2010
1
0.360
Why?
Multiple Trauma
1
2010
2
0.360
Why?
Rib Fractures
1
2010
2
0.360
Why?
Neoplasms
3
2022
445
0.350
Why?
Mycobacterium Infections, Nontuberculous
2
2022
12
0.340
Why?
Biomarkers, Tumor
3
2021
144
0.330
Why?
MicroRNAs
2
2021
16
0.330
Why?
Aged
15
2025
6173
0.330
Why?
Electronic Health Records
4
2023
698
0.330
Why?
Carcinoma, Ductal, Breast
2
2021
53
0.320
Why?
Heart Failure
1
2014
396
0.310
Why?
Middle Aged
18
2025
8020
0.310
Why?
Female
19
2025
12780
0.300
Why?
United States
11
2025
4007
0.260
Why?
Tomography, X-Ray Computed
5
2025
211
0.240
Why?
Skin Diseases, Papulosquamous
1
2005
1
0.240
Why?
CD56 Antigen
1
2005
1
0.240
Why?
Killer Cells, Natural
1
2005
3
0.240
Why?
CD4 Antigens
1
2005
2
0.240
Why?
Exanthema
1
2005
7
0.240
Why?
Lymphoma, T-Cell, Cutaneous
1
2005
4
0.240
Why?
Health Services Research
2
2016
232
0.240
Why?
Delivery of Health Care
5
2019
417
0.230
Why?
Occult Blood
2
2022
154
0.230
Why?
Guideline Adherence
1
2025
158
0.220
Why?
ras Proteins
2
2014
20
0.220
Why?
Proto-Oncogene Proteins
2
2014
32
0.220
Why?
Melanoma
1
2024
35
0.220
Why?
Deductibles and Coinsurance
1
2023
30
0.210
Why?
Patient Compliance
1
2025
301
0.210
Why?
RNA, Ribosomal, 16S
1
2022
4
0.210
Why?
Opportunistic Infections
1
2022
7
0.200
Why?
Prepaid Health Plans
1
2022
20
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
50
0.200
Why?
Myxoma
1
2002
1
0.200
Why?
Adult
10
2024
7708
0.200
Why?
Skin Pigmentation
1
2002
6
0.200
Why?
Testicular Neoplasms
1
2002
11
0.200
Why?
Population Surveillance
1
2024
264
0.200
Why?
Neoplasms, Multiple Primary
1
2002
18
0.200
Why?
Biological Specimen Banks
1
2022
12
0.200
Why?
Feces
1
2022
80
0.190
Why?
Population Dynamics
1
2021
6
0.190
Why?
Breast Neoplasms
2
2021
957
0.190
Why?
Preventive Medicine
1
2021
24
0.190
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2021
40
0.190
Why?
Aged, 80 and over
7
2025
1931
0.190
Why?
Transfusion-Related Acute Lung Injury
1
2021
1
0.180
Why?
Transfusion Reaction
1
2021
2
0.180
Why?
Blood Transfusion
1
2021
3
0.180
Why?
Respiratory Insufficiency
1
2021
17
0.180
Why?
Cancer Survivors
1
2022
85
0.180
Why?
Colonoscopy
1
2022
253
0.170
Why?
Retrospective Studies
6
2025
2467
0.170
Why?
Models, Organizational
1
2019
55
0.170
Why?
Neoplasm Recurrence, Local
2
2025
247
0.160
Why?
Prospective Studies
1
2022
1286
0.160
Why?
Genetic Testing
3
2014
72
0.150
Why?
Lung
3
2024
62
0.150
Why?
Gene Library
1
2017
3
0.140
Why?
Paraffin Embedding
1
2017
5
0.140
Why?
Cohort Studies
5
2022
2590
0.140
Why?
Sequence Analysis, DNA
1
2017
30
0.140
Why?
ErbB Receptors
2
2016
5
0.140
Why?
Tuberculosis
1
2017
23
0.140
Why?
Serum Albumin
2
2009
4
0.140
Why?
Mixed Tumor, Malignant
1
2016
1
0.130
Why?
Mixed Tumor, Mullerian
1
2016
1
0.130
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
1
0.130
Why?
Heparin-binding EGF-like Growth Factor
1
2016
1
0.130
Why?
Cell Movement
1
2016
5
0.130
Why?
Uterine Neoplasms
1
2016
14
0.130
Why?
Angiostrongylus cantonensis
1
2015
1
0.130
Why?
Strongylida Infections
1
2015
1
0.130
Why?
DNA, Helminth
1
2015
1
0.130
Why?
Meningitis
1
2015
3
0.130
Why?
Eosinophilia
1
2015
2
0.130
Why?
Real-Time Polymerase Chain Reaction
1
2015
12
0.130
Why?
Adolescent
6
2022
3690
0.120
Why?
Smoking
3
2023
484
0.120
Why?
Pragmatic Clinical Trials as Topic
1
2015
61
0.120
Why?
Glomus Jugulare
1
2013
1
0.110
Why?
Glomus Jugulare Tumor
1
2013
1
0.110
Why?
Neoplasm Staging
3
2025
330
0.110
Why?
Hawaii
3
2022
44
0.110
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2013
15
0.110
Why?
Research Design
1
2015
376
0.100
Why?
Molecular Targeted Therapy
1
2012
6
0.100
Why?
Child, Preschool
3
2021
1424
0.090
Why?
Diagnosis, Differential
1
2010
60
0.090
Why?
Influenza B virus
1
2010
9
0.090
Why?
Biomarkers
2
2009
310
0.090
Why?
Influenza A virus
1
2010
13
0.090
Why?
Laboratories
1
2010
18
0.090
Why?
Disease Outbreaks
1
2010
36
0.090
Why?
Fatty Acids
1
2009
8
0.080
Why?
Myocardial Infarction
2
2009
238
0.080
Why?
Acute Coronary Syndrome
1
2009
18
0.080
Why?
National Cancer Institute (U.S.)
2
2020
16
0.080
Why?
Quality Assurance, Health Care
1
2010
169
0.080
Why?
Child
3
2021
2497
0.080
Why?
Mutation
3
2014
131
0.080
Why?
Health Status Disparities
2
2020
147
0.080
Why?
Incidence
2
2022
1269
0.080
Why?
Myocardial Ischemia
2
2009
24
0.070
Why?
Young Adult
3
2022
2464
0.070
Why?
Influenza, Human
1
2010
265
0.070
Why?
Data Collection
2
2019
257
0.060
Why?
Pilot Projects
2
2021
219
0.060
Why?
Insulinoma
1
2005
1
0.060
Why?
Practice Guidelines as Topic
2
2019
321
0.060
Why?
Infant
2
2021
1198
0.060
Why?
Recurrence
1
2025
189
0.060
Why?
Treatment Outcome
3
2016
1265
0.060
Why?
Neoplasm Metastasis
2
2014
31
0.060
Why?
Proto-Oncogene Proteins p21(ras)
2
2014
21
0.050
Why?
Immunotherapy
1
2023
6
0.050
Why?
Cobalt
1
2003
1
0.050
Why?
Pancreatic Neoplasms
1
2005
67
0.050
Why?
Nontuberculous Mycobacteria
1
2022
7
0.050
Why?
Neurilemmoma
1
2002
1
0.050
Why?
Cushing Syndrome
1
2002
2
0.050
Why?
Medicare
1
2023
205
0.050
Why?
Risk Assessment
2
2019
1103
0.050
Why?
Prognosis
2
2014
609
0.050
Why?
Community-Based Participatory Research
1
2021
61
0.050
Why?
United States Food and Drug Administration
1
2021
34
0.050
Why?
Respiration, Artificial
1
2021
37
0.040
Why?
Prevalence
1
2023
888
0.040
Why?
International Classification of Diseases
1
2021
85
0.040
Why?
Insurance, Health
1
2022
183
0.040
Why?
Hospitals
1
2021
80
0.040
Why?
Inpatients
1
2021
81
0.040
Why?
Pandemics
1
2022
287
0.040
Why?
Community Health Planning
1
2019
19
0.040
Why?
Geography
1
2019
39
0.040
Why?
Predictive Value of Tests
1
2021
354
0.040
Why?
Liquid Biopsy
1
2019
3
0.040
Why?
Molecular Diagnostic Techniques
1
2019
7
0.040
Why?
Registries
1
2022
472
0.040
Why?
Tobacco Use Cessation
1
2019
22
0.040
Why?
Health Plan Implementation
1
2019
36
0.040
Why?
Public Health Surveillance
1
2019
42
0.040
Why?
Databases, Factual
1
2021
315
0.040
Why?
Precision Medicine
1
2019
28
0.040
Why?
Cost of Illness
1
2019
93
0.040
Why?
Research
1
2019
65
0.040
Why?
Body Mass Index
1
2023
967
0.040
Why?
Disease Management
1
2019
135
0.040
Why?
Counseling
1
2019
189
0.040
Why?
Socioeconomic Factors
1
2019
630
0.040
Why?
MCF-7 Cells
1
2017
4
0.040
Why?
Lung Diseases
1
2017
42
0.030
Why?
Protein Binding
2
2009
9
0.030
Why?
Integrin alpha5
1
2016
1
0.030
Why?
Tissue Array Analysis
1
2016
1
0.030
Why?
Immunohistochemistry
1
2016
44
0.030
Why?
Neoplasm Invasiveness
1
2016
78
0.030
Why?
Hospitalization
1
2021
810
0.030
Why?
Animals
1
2015
262
0.030
Why?
Cooperative Behavior
1
2015
92
0.030
Why?
Combined Modality Therapy
1
2014
147
0.030
Why?
Medical History Taking
1
2013
35
0.030
Why?
Family Health
1
2013
44
0.030
Why?
Magnetic Resonance Imaging
1
2013
107
0.030
Why?
Medical Records
1
2013
100
0.030
Why?
Drug Administration Schedule
1
2012
100
0.030
Why?
Analysis of Variance
1
2012
159
0.030
Why?
Dose-Response Relationship, Drug
1
2012
129
0.030
Why?
Antineoplastic Agents
1
2012
59
0.020
Why?
Confidence Intervals
1
2012
237
0.020
Why?
Survival Rate
1
2012
260
0.020
Why?
Multivariate Analysis
1
2012
569
0.020
Why?
DNA, Viral
1
2010
17
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
27
0.020
Why?
Sentinel Surveillance
1
2010
12
0.020
Why?
Residence Characteristics
1
2012
251
0.020
Why?
Quality Control
1
2010
45
0.020
Why?
Logistic Models
1
2012
928
0.020
Why?
Sensitivity and Specificity
1
2010
305
0.020
Why?
Risk Factors
1
2014
3362
0.020
Why?
Immunoenzyme Techniques
1
2005
20
0.020
Why?
Pancreas
1
2005
14
0.010
Why?
Binding Sites
1
2003
2
0.010
Why?
Indicators and Reagents
1
2003
5
0.010
Why?
ROC Curve
1
2003
77
0.010
Why?
Concepts (199)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente